We also collaborated with PathAI, a leader in artificial intelligence-powered research in pathology, to evaluate machine learning approaches to liver histology assessment for use in diagnosis and treatment monitoring for nonalcoholic steatohepatitis (NASH), a disease that causes fat accumulation and inflammation in the liver and can lead to liver fibrosis and the need for liver transplantation.